Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga · 12/08/2025 13:03
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.
Shares of Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) fell sharply in pre-market trading after the company announced that it will be delisted from the Nasdaq.
Meihua International Medical Technologies shares dipped 32.9% to $9.41 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares dipped 17.2% to $275.00 in pre-market trading after jumping 135% on Friday.
- Gulf Resources, Inc. (NASDAQ:GURE) shares declined 16.1% to $6.87 in pre-market trading after declining 4% on Friday.
- Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) fell 16.1% to $5.35 in pre-market trading after surging 98% on Friday.
- Fly-E Group, Inc. (NASDAQ:FLYE) declined 14.4% to $7.08 in pre-market trading. Fly-E Group announced receipt of delinquency notice from Nasdaq regarding delayed Form 10-Q.
- Ecarx Holdings Inc. (NASDAQ:ECX) fell 9.1% to $1.91 in pre-market trading after gaining 8% on Friday.
- Arteris Inc (NASDAQ:AIP) fell 7.1% to $16.30 in pre-market trading.
- Veracyte Inc (NASDAQ:VCYT) fell 5.7% to $42.06 in pre-market trading after declining 6% on Friday.
- Chagee Holdings Ltd (NASDAQ:CHA) shares declined 4.6% to $13.91 in pre-market trading.
- PureTech Health PLC (NASDAQ:PRTC) fell 4.2% to $17.30 in pre-market trading. PureTech announced successful end-of-Phase 2 meeting with the FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis.
- PepGen Inc (NASDAQ:PEPG) declined 3.9% to $5.23 in pre-market trading.
Now Read This:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.